risks of taking glp 1 GLP-1 Agonists In Obesity GLP-1 medication side effects for

Reports from Q4 2003 to Q1 2024 were analyzed using the OpenVigil 2.1 platform to identify male patients experiencing orgasmic dysfunction, erectile dysfunction, or decreased libido linked to GLP-1 receptor agonists (tirzepatide, semaglutide, dulaglutide, exenatide, lixisenatide, and liraglutide)

Genuine medicines available at affordable prices nationwide.

FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs

Ensures proper hydration and electrolyte balance

Currently, there are more than 1 billion people worldwide with obesity, many of whom also have type 2 diabetes mellitus or prediabetes